| Protein Name | Apoptosis-Inducing Factor, Mitochondria-Associated 1 |
|---|---|
| Gene | [AIFM1](/genes/aifm1) |
| UniProt ID | O95831 |
| Protein Size | 613 amino acids (~63 kDa) |
| Subcellular Localization | Inner mitochondrial membrane (mature form); nucleus (during apoptosis) |
| Protein Family | FAD-dependent oxidoreductases; AIF family |
| PDB Structures | 1GV4, 1M6I, 3PHC |
Apoptosis-Inducing Factor (AIF) is a crucial flavoprotein that plays dual roles in both normal mitochondrial function and programmed cell death. As a key mediator of caspase-independent apoptosis, AIF translocates from mitochondria to the nucleus upon apoptotic stimuli, where it triggers large-scale DNA fragmentation and chromatin condensation.
The AIF protein contains several distinct structural domains:
The crystal structure reveals a compact globular fold with the FAD-binding domain forming the core of the protein.
In healthy cells, AIF performs essential mitochondrial functions:
Oxidative Phosphorylation: AIF is essential for the assembly and stability of mitochondrial complex I (NADH:ubiquinone oxidoreductase). Loss of AIF leads to severe defects in complex I activity and ATP production[1].
Mitochondrial Morphology: AIF helps maintain normal mitochondrial morphology and cristae structure.
Redox Regulation: The FAD-dependent enzymatic activity allows AIF to participate in cellular redox reactions and antioxidant defense.
DNA Repair: Nuclear AIF can interact with DNA repair proteins to maintain genomic stability.
Recessive mutations in AIFM1 cause X-linked Charcot-Marie-Tooth disease type 4, characterized by peripheral neuropathy, axonal degeneration, and sometimes cognitive impairment[2].
Loss-of-function mutations lead to severe multisystem disorders affecting brain development, causing encephalomyopathy, lactic acidosis, and early-onset neurodegeneration[3].
AIF is sequestered in the cytoplasm in AD brains and translocates to the nucleus in response to amyloid-beta toxicity, contributing to neuronal DNA damage and death[4].
Mitochondrial dysfunction in PD involves impaired AIF function, and PARP-1 activation leads to AIF-mediated cell death (parthanatos)[5].
AIF translocation from mitochondria to nucleus is observed in ALS motor neurons, contributing to progressive neurotoxicity.
Current therapeutic approaches targeting AIF pathway:
AIF interacts with several key proteins: